Changing trends of mortality in gout

Area of Science:

• Rheumatology
• Cardiology
• Epidemiology

Background:

• Gout, a metabolic disorder affecting uric acid levels, has been historically associated with increased mortality risks.
• Coronary heart disease (CHD) is a significant cause of death in the general population and among individuals with gout.

Purpose of the Study:

• To investigate the long-term survival rates of patients with primary gout compared to the general male population.
• To analyze mortality trends, particularly from CHD, in gout patients relative to population-wide changes.

Main Methods:

• Comparative survival analysis of primary gout patients versus a matched general male population.
• Examination of mortality data, focusing on causes of death including CHD.

Main Results:

• Patients with primary gout exhibit comparable life expectancies to their non-gouty counterparts.
• Mortality rates, especially from CHD, have declined in gout patients mirroring trends in the general population.
• Disturbances in uric acid metabolism do not appear to confer a significantly increased inherent risk for morbidity or mortality.

Conclusions:

• Primary gout does not significantly reduce overall life expectancy.
• Lifestyle modifications and management of major risk factors likely contribute to improved outcomes in gout patients.
• Uric acid metabolism disturbance alone is not a major independent predictor of increased mortality risk.